VGLL4 anticorps (AA 136-163)

N° du produit ABIN1881992

L’anticorps Lapin Polyclonal anti-VGLL4 a été validé pour WB. Il convient pour détecter VGLL4 dans des échantillons de Humain. Il y a 2+ publications disponibles.

Aperçu rapide pour VGLL4 anticorps (AA 136-163) (ABIN1881992)

Antigène: VGLL4 (Vestigial Like 4 (VGLL4))

Reactivité: Humain

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp VGLL4 est non-conjugé

Application: Western Blotting (WB)

Clone: RB40616

Détail du produit anti-VGLL4 anticorps

Épitope: AA 136-163

Purification: This antibody is purified through a protein A column, followed by peptide affinity purification.

Immunogène: This VGLL4 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 136-163 amino acids from the Central region of human VGLL4.

Isotype: Ig Fraction

Information d'application

Indications d'application: WB: 1:1000

Restrictions: For Research Use only

Stockage

Format: Liquid

Buffer: Purified polyclonal antibody supplied in PBS with 0.09 % (W/V) sodium azide.

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: 4 °C,-20 °C

Date de péremption: 6 months

Références pour anticorps anti-VGLL4 (ABIN1881992)

Trynka, Zhernakova, Romanos, Franke, Hunt, Turner, Bruinenberg, Heap, Platteel, Ryan, de Kovel, Holmes, Howdle, Walters, Sanders, Mulder, Mearin, Verbeek, Trimble, Stevens, Kelleher, Barisani et al.: "Coeliac disease-associated risk variants in TNFAIP3 and REL implicate altered NF-kappaB signalling. ..." dans: Gut, Vol. 58, Issue 8, pp. 1078-83, (2009) (PubMed).

Chen, Mullett, Stewart: "Vgl-4, a novel member of the vestigial-like family of transcription cofactors, regulates alpha1-adrenergic activation of gene expression in cardiac myocytes." dans: The Journal of biological chemistry, Vol. 279, Issue 29, pp. 30800-6, (2004) (PubMed).

Détails sur VGLL4

Antigène: VGLL4 (Vestigial Like 4 (VGLL4))

Autre désignation: VGLL4

Sujet: VGLL4 may act as a specific coactivator for the mammalian TEFs (By similarity).

Poids moléculaire: 30948

NCBI Accession: NP_001121691, NP_001121692, NP_001121693, NP_055482

UniProt: Q14135